MTAP loss in metastatic breast cancer patients: Genomic landscape

by

A new research paper titled “Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss” has been published in Oncotarget.

Leave A Comment

Your email address will not be published. Required fields are marked *